ConductScience.org, home

Paper15230342

Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?

Caldwell GW and 3 others. Eur J Drug Metab Pharmacokinet, 2004. Cited by 106 papers, by iCite.

Cite this record

ConductScience Library. Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data? Papers, record 15230342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15230342

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?
PubMed
Journal
Eur J Drug Metab Pharmacokinet
PubMed
Year
2004
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
106
iCite
Relative citation ratio, by iCite
3.12
iCite
Revised in PubMed
2026-10-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Caldwell GWGary W
2Masucci JAJohn A
3Yan ZZhengyin
4Hageman WWilliam

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug DesignMajor topic
PharmacokineticsMajor topic
Algorithms
Animals
Half-Life
Humans
Predictive Value of Tests
Rats
Regression Analysis
Species Specificity

Source PubMed

Download CSV of topics

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19834005Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats.Pharm Res1998https://conductscience.org/library/papers/9834005PubMed
28727426Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics.Med Res Rev1996https://conductscience.org/library/papers/8727426PubMed
32654032The absolute oral bioavailability of selected drugs.Int J Clin Pharmacol Ther Toxicol1989https://conductscience.org/library/papers/2654032PubMed
49370523Estimating xenobiotic half-lives in humans from rat data: influence of log P.Environ Health Perspect1997https://conductscience.org/library/papers/9370523PubMed
512433818Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved, and sandwich-cultured hepatocytes.Drug Metab Dispos2002https://conductscience.org/library/papers/12433818PubMed
610534321Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.Drug Metab Dispos1999https://conductscience.org/library/papers/10534321PubMed
710223169Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations.Clin Pharmacokinet1999https://conductscience.org/library/papers/10223169PubMed
810962646Can absolute oral bioavailability in humans be predicted from animals? A comparison of allometry and different indirect methods.Drug Metabol Drug Interact2000https://conductscience.org/library/papers/10962646PubMed
911097145Similarity in the linear and non-linear oral absorption of drugs between human and rat.Int J Clin Pharmacol Ther2000https://conductscience.org/library/papers/11097145PubMed
1012049492Allometric scaling of xenobiotic clearance: uncertainty versus universality.AAPS PharmSci2001https://conductscience.org/library/papers/12049492PubMed
113244618Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds.Pharm Res1988https://conductscience.org/library/papers/3244618PubMed
1212134959Comparison of oral absorption and bioavailablity of drugs between monkey and human.Pharm Res2002https://conductscience.org/library/papers/12134959PubMed
137598498Risk assessment of environmental chemicals.Annu Rev Pharmacol Toxicol1995https://conductscience.org/library/papers/7598498PubMed
149691080High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds.Curr Opin Chem Biol1998https://conductscience.org/library/papers/9691080PubMed
159336307The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.J Pharmacol Exp Ther1997https://conductscience.org/library/papers/9336307PubMed
1610322290Novel procedure for rapid pharmacokinetic screening of discovery compounds in rats.Drug Discov Today1999https://conductscience.org/library/papers/10322290PubMed
1711804393Pharmacokinetics and interspecies scaling of a novel VEGF receptor inhibitor, SU5416.J Pharm Pharmacol2001https://conductscience.org/library/papers/11804393PubMed
1811121732The role of P-glycoprotein in determining the oral absorption and clearance of the NK2 antagonist, UK-224,671.Eur J Pharm Sci2000https://conductscience.org/library/papers/11121732PubMed
1910870984Allometric pharmacokinetic scaling: towards the prediction of human oral pharmacokinetics.Pharm Res2000https://conductscience.org/library/papers/10870984PubMed
2012434392Prediction of human clearance from animal data and molecular structural parameters using multivariate regression analysis.J Pharm Sci2002https://conductscience.org/library/papers/12434392PubMed

See all 50 referencesDownload CSV of references

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.

PMIDTitleJournalYearIn PapersSource
42514902Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions.Pharmaceutics2026https://conductscience.org/library/papers/42514902PubMed
42395903
Fucus vesiculosus fucoidan alone and in combination with simvastatin is associated with both alleviation of atherosclerosis and modulations in the gut microbiota and its metabolites in New Zealand rabbits.
Front Microbiol2026https://conductscience.org/library/papers/42395903PubMed
42370792Discovery of PIPE-791, A Potent and Brain-Penetrant Lysophosphatidic Acid Receptor 1 Antagonist with Slow Tight Binding Characteristics for the Treatment of Neuroinflammatory Disorders.J Med Chem2026https://conductscience.org/library/papers/42370792PubMed
41388842GLP-2 and GIP acutely increase superior mesenteric artery blood flow in male rats, and the effect is independent of nitric oxide and vasoactive intestinal peptide.Physiol Rep2025https://conductscience.org/library/papers/41388842PubMed
41252611What Do Oral Drugs Really Look Like? Dose Regimen, Pharmacokinetics, and Safety of Recently Approved Small-Molecule Oral Drugs.J Med Chem2025https://conductscience.org/library/papers/41252611PubMed
41013647PKSmart: an open-source computational model to predict intravenous pharmacokinetics of small molecules.J Cheminform2025https://conductscience.org/library/papers/41013647PubMed
41009591A Sensitive SPE-LC-MS/MS Method for Determination of Selected Veterinary Drugs and Other Organic Contaminants in Human Urine: Development, Validation, and Application Study.Int J Mol Sci2025https://conductscience.org/library/papers/41009591PubMed
40933709Pharmacometric modeling of lipid nanoparticle-encapsulated mRNA therapeutics and vaccines: A systematic review.Mol Ther Nucleic Acids2025https://conductscience.org/library/papers/40933709PubMed
40931222Fraction-based Linear Extrapolation (FLEX) Method for Predicting Human Pharmacokinetic Clearance: Advanced Allometric Scaling Method and Machine Learning Approach.Pharm Res2025https://conductscience.org/library/papers/40931222PubMed
40916570Half-life prediction of central nervous system (CNS) small molecules in humans using gradient tree boosting.Future Med Chem2025https://conductscience.org/library/papers/40916570PubMed
40839051From structure to strategy: chemometric modeling for the prediction of terminal half-life of pharmaceuticals and its role in future therapeutics.Mol Divers2026https://conductscience.org/library/papers/40839051PubMed
39659642Evaluating the effects of ivacaftor exposure on Staphylococcus aureus small colony variant development and antibiotic tolerance.JAC Antimicrob Resist2024https://conductscience.org/library/papers/39659642PubMed
39065664Development of a Clonal and High-Yield Mammalian Cell Line for the Manufacturing of a Hyperactive Human DNase I with Extended Plasma Half-Life Using PASylation® Technology.Pharmaceutics2024https://conductscience.org/library/papers/39065664PubMed
37573009Consideration of vendor-related differences in hepatic metabolic stability data to optimize early ADME screening in drug discovery.SLAS Discov2024https://conductscience.org/library/papers/37573009PubMed
37375183Assessing Boron-Pleuromutilin AN11251 for the Development of Antibacterial Agents.Molecules2023https://conductscience.org/library/papers/37375183PubMed
37242468Application of the Population Pharmacokinetics Model-Based Approach to the Prediction of Drug-Drug Interaction between Rivaroxaban and Carbamazepine in Humans.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37242468PubMed
37052732In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes.AAPS J2023https://conductscience.org/library/papers/37052732PubMed
35041507Preclinical Pharmacokinetics and Safety of Intravenous RTD-1.Antimicrob Agents Chemother2022https://conductscience.org/library/papers/35041507PubMed
34930820RTICBM-74 Is a Brain-Penetrant Cannabinoid Receptor Subtype 1 Allosteric Modulator that Reduces Alcohol Intake in Rats.J Pharmacol Exp Ther2022https://conductscience.org/library/papers/34930820PubMed
34120326Comparison of Various Approaches to Translate Non-Linear Pharmacokinetics of Monoclonal Antibodies from Cynomolgus Monkey to Human.Eur J Drug Metab Pharmacokinet2021https://conductscience.org/library/papers/34120326PubMed

See all 44 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15230342

GET https://conductscience.org/api/papers/v1/15230342/references?page=2